JP2025501922A5 - - Google Patents
Info
- Publication number
- JP2025501922A5 JP2025501922A5 JP2024538962A JP2024538962A JP2025501922A5 JP 2025501922 A5 JP2025501922 A5 JP 2025501922A5 JP 2024538962 A JP2024538962 A JP 2024538962A JP 2024538962 A JP2024538962 A JP 2024538962A JP 2025501922 A5 JP2025501922 A5 JP 2025501922A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298551P | 2022-01-11 | 2022-01-11 | |
| US63/298,551 | 2022-01-11 | ||
| PCT/US2023/010493 WO2023137018A1 (en) | 2022-01-11 | 2023-01-10 | Uses of a somatostatin modulator for the treatment of carcinoid syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501922A JP2025501922A (ja) | 2025-01-24 |
| JP2025501922A5 true JP2025501922A5 (enExample) | 2026-01-07 |
Family
ID=87279605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538962A Pending JP2025501922A (ja) | 2022-01-11 | 2023-01-10 | カルチノイド症候群の治療のためのソマトスタチンモジュレータの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250228842A1 (enExample) |
| EP (1) | EP4463159A4 (enExample) |
| JP (1) | JP2025501922A (enExample) |
| KR (1) | KR20240132451A (enExample) |
| CN (1) | CN118510511A (enExample) |
| AU (1) | AU2023207068A1 (enExample) |
| CA (1) | CA3242165A1 (enExample) |
| IL (1) | IL314054A (enExample) |
| MX (1) | MX2024008598A (enExample) |
| TW (1) | TW202339747A (enExample) |
| WO (1) | WO2023137018A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4482491A4 (en) * | 2022-02-25 | 2026-02-25 | Amryt Endo Inc | ORAL OCTREOTIDE FOR THE TREATMENT OF A DISEASE |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
| AU2017296392B2 (en) * | 2016-07-14 | 2020-09-24 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| MA51625B1 (fr) * | 2018-01-17 | 2022-07-29 | Crinetics Pharmaceuticals Inc | Procédé de production de modulateurs de somatostatine |
| US12617767B2 (en) * | 2019-07-17 | 2026-05-05 | Crinetics Pharmaceuticals, Inc. | Crystalline forms of somatostatin modulators |
| WO2022055880A1 (en) * | 2020-09-09 | 2022-03-17 | Crinetics Pharmaceuticals, Inc. | Formulations of a somatostatin modulator |
-
2023
- 2023-01-10 IL IL314054A patent/IL314054A/en unknown
- 2023-01-10 CA CA3242165A patent/CA3242165A1/en active Pending
- 2023-01-10 AU AU2023207068A patent/AU2023207068A1/en active Pending
- 2023-01-10 JP JP2024538962A patent/JP2025501922A/ja active Pending
- 2023-01-10 CN CN202380016138.8A patent/CN118510511A/zh active Pending
- 2023-01-10 WO PCT/US2023/010493 patent/WO2023137018A1/en not_active Ceased
- 2023-01-10 MX MX2024008598A patent/MX2024008598A/es unknown
- 2023-01-10 KR KR1020247021853A patent/KR20240132451A/ko active Pending
- 2023-01-10 EP EP23740602.0A patent/EP4463159A4/en active Pending
- 2023-01-10 US US18/727,827 patent/US20250228842A1/en active Pending
- 2023-01-10 TW TW112101029A patent/TW202339747A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW576743B (en) | Extended release formulations of erythromycin derivatives | |
| EP1077704A1 (en) | Combination therapy for treatment of depression | |
| JP2012006923A (ja) | 糖尿病の治療及び予防のためのフタリド誘導体の使用 | |
| US20250241897A1 (en) | Composition for eradicating helicobacter pylori | |
| JP2025541969A (ja) | アラジール症候群（ａｌｇｓ）の処置 | |
| FR2904774A1 (fr) | Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent. | |
| JP2004525940A (ja) | 火照りの処置のためのデュロキセチン | |
| HUE034155T2 (en) | Therapeutic uses of 1- [2- (2,4-dimethylphenylsulfanyl) phenyl] piperazine | |
| TWI777059B (zh) | 肌肉減少症之預防劑及治療劑 | |
| CN118845777B (zh) | 一种克诺拉尼用作淋巴水肿治疗剂的用途 | |
| TW202228679A (zh) | 用於口服投予的包含１－（３－氰基－１－異丙基－吲哚－５－基）吡唑－４－羧酸之複合調製劑和製備彼之方法 | |
| JP2011517678A (ja) | 過活動膀胱の治療のためのウデナフィル、およびアルフゾシンまたはオキシブチニンの組み合わせの使用 | |
| US20240100011A1 (en) | Pediatric formulations of ferric citrate | |
| CN105579036B (zh) | 用于改善膀胱尿道协同失调的药剂 | |
| JP5094197B2 (ja) | 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物 | |
| US5876751A (en) | Antispasmodic and antinflammatory composition and a process for the manufacture thereof | |
| KR20220168172A (ko) | 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산을 포함하는 약학적 조성물 | |
| KR20220111620A (ko) | 코비드-19 감염증의 예방 또는 치료용 약제학적 조성물 | |
| CN112999226A (zh) | 用于治疗类风湿性关节炎的药物组合物 | |
| CN101370520A (zh) | 用于心力衰竭的预防或治疗的医药组合物 | |
| CN112716945B (zh) | 药物组合物及其应用 | |
| WO2005063253A1 (ja) | アレルギー症状治療用医薬組成物 | |
| EP3981423B1 (en) | Composition for preventing or treating uric acid-related disease | |
| KR101336499B1 (ko) | 당뇨병의 예방 또는 치료용 복합 조성물 | |
| JP5440502B2 (ja) | 過敏性腸症候群の治療方法 |